Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2007 | 1 |
2009 | 1 |
2011 | 1 |
2013 | 1 |
2015 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma.
Int J Mol Sci. 2013 May 29;14(6):11402-23. doi: 10.3390/ijms140611402.
Int J Mol Sci. 2013.
PMID: 23759990
Free PMC article.
Review.
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer.
Oosterwijk-Wakka JC, de Weijert MCA, Franssen GM, Kolev DR, de Haan TAFJ, Boerman OC, Mulders PFA, Oosterwijk E.
Oosterwijk-Wakka JC, et al.
Neoplasia. 2022 Oct;32:100826. doi: 10.1016/j.neo.2022.100826. Epub 2022 Jul 22.
Neoplasia. 2022.
PMID: 35878454
Free PMC article.
Item in Clipboard
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg.
Bauer S, Oosterwijk-Wakka JC, Adrian N, Oosterwijk E, Fischer E, Wüest T, Stenner F, Perani A, Cohen L, Knuth A, Divgi C, Jäger D, Scott AM, Ritter G, Old LJ, Renner C.
Bauer S, et al. Among authors: oosterwijk wakka jc.
Int J Cancer. 2009 Jul 1;125(1):115-23. doi: 10.1002/ijc.24359.
Int J Cancer. 2009.
PMID: 19384924
Free article.
Item in Clipboard
Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells.
Bleumer I, Tiemessen DM, Oosterwijk-Wakka JC, Völler MC, De Weijer K, Mulders PF, Oosterwijk E.
Bleumer I, et al. Among authors: oosterwijk wakka jc.
J Immunother. 2007 Jan;30(1):116-22. doi: 10.1097/01.cji.0000211318.22902.ec.
J Immunother. 2007.
PMID: 17198090
Clinical Trial.
Item in Clipboard
Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.
Oosterwijk-Wakka JC, de Weijert MC, Franssen GM, Leenders WP, van der Laak JA, Boerman OC, Mulders PF, Oosterwijk E.
Oosterwijk-Wakka JC, et al.
Neoplasia. 2015 Feb;17(2):215-24. doi: 10.1016/j.neo.2014.12.011.
Neoplasia. 2015.
PMID: 25748241
Free PMC article.
Item in Clipboard
Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250.
Oosterwijk-Wakka JC, Kats-Ugurlu G, Leenders WP, Kiemeney LA, Old LJ, Mulders PF, Oosterwijk E.
Oosterwijk-Wakka JC, et al.
BJU Int. 2011 Jan;107(1):118-25. doi: 10.1111/j.1464-410X.2010.09314.x.
BJU Int. 2011.
PMID: 20346054
Item in Clipboard
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.
Oosterwijk-Wakka JC, Tiemessen DM, Bleumer I, de Vries IJ, Jongmans W, Adema GJ, Debruyne FM, de Mulder PH, Oosterwijk E, Mulders PF.
Oosterwijk-Wakka JC, et al.
J Immunother. 2002 Nov-Dec;25(6):500-8. doi: 10.1097/00002371-200211000-00006.
J Immunother. 2002.
PMID: 12439347
Clinical Trial.
Item in Clipboard
Cite
Cite